BlackRock’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
Other funds holding BBH
MIM
CCA
BFG
BlackRock's BBH Position: Q2 2026 in Review
BlackRock held its VanEck Biotech ETF (BBH) position steady in Q2 2026 at 165 shares worth $33.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5271.
BlackRock first reported a position in BBH in Q2 2025 and has held it in 5 quarters since. 110 funds tracked by Wall St. Rank hold BBH as of Q2 2026.
- BlackRock held 165 shares of VanEck Biotech ETF worth $33.5K as of Q2 2026.
- BlackRock left its VanEck Biotech ETF share count unchanged in Q2 2026.
- VanEck Biotech ETF made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5271 holding.
- BlackRock first reported a position in VanEck Biotech ETF in Q2 2025 and has held it in 5 quarters since.
- 110 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.